USFDA gearing up for rapid review of potential COVID-19 booster shots

Dr. Janet Woodcock, acting commissioner of the FDA, said that if new variants of the coronavirus emerge that require booster shots or changes to vaccines, the agency will not require the type of large trials that were required for emergency use authorization or approval.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2MyrI9i
via IFTTT